It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
In two whistleblower suits filed in May 2009, the United States and 16 states alleged that Wyeth (Madison, NJ) knowingly failed to offer the government the same discounts it gave to private purchasers of its drugs, as Medicaid laws require. The suits allege that Wyeth owes hundreds of millions of dollars in rebates to state Medicaid programs for its Protonix Oral and Protonix IV products.
The Medicaid Drug Rebate Program requires the manufacturers of branded pharmaceuticals to report the prices they charge their customers, including the “best price” offered for their drugs. Drugmakers
Users of Premarin drug stunned by price hike
Women who take the hormone replacement therapy drug Premarin are getting a big case of sticker shock when they renew their prescriptions these days.
That's because as of April 1, a month's supply of the medication has risen an astonishing 800 per cent, from about 14 cents a pill to about $1.24 a pill.
The price hike isn't due to any changes in the drug's formulation or packaging; it's simply a matter of supply and demand, says its manufacturer, Wyeth Canada.